|
1
|
Bousquet J, Anto JM, Bachert C, Baiardini
I, Bosnic-Anticevich S, Walter Canonica G, Melén E, Palomares O,
Scadding GK, Togias A and Toppila-Salmi S: Allergic rhinitis. Nat
Rev Dis Primers. 6:952020.
|
|
2
|
Zhang Y, Lan F and Zhang L: Update on
pathomechanisms and treatments in allergic rhinitis. Allergy.
77:3309–3319. 2022.
|
|
3
|
Liu P, Kang C, Zhang J, Liu Y, Liu J, Hu
T, Zeng X and Qiu S: The role of dendritic cells in allergic
diseases. Int Immunopharmacol. 113:1094492022.
|
|
4
|
Hodge AL, Baxter AA and Poon IKH: Gift
bags from the sentinel cells of the immune system: The diverse role
of dendritic cell-derived extracellular vesicles. J Leukoc Biol.
111:903–920. 2022.
|
|
5
|
Zheng Z and Yu Y: A review of recent
advances in exosomes and allergic rhinitis. Front Pharmacol.
13:10969842022.
|
|
6
|
Zhang Y, Bi J, Huang J, Tang Y, Du S and
Li P: Exosome: A review of its classification, isolation
techniques, storage, diagnostic and targeted therapy applications.
Int J Nanomedicine. 15:6917–6934. 2020.
|
|
7
|
Elashiry M, Elsayed R, Elashiry MM, Rashid
MH, Ara R, Arbab AS, Elawady AR, Hamrick M, Liu Y, Zhi W, et al:
Proteomic characterization, biodistribution, and functional studies
of immune-therapeutic exosomes: Implications for inflammatory lung
diseases. Front Immunol. 12:6362222021.
|
|
8
|
Ibrahim A and Marbán E: Exosomes:
Fundamental biology and roles in cardiovascular physiology. Annu
Rev Physiol. 78:67–83. 2016.
|
|
9
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367:eaau69772020.
|
|
10
|
Liu J, Ren L, Li S, Li W, Zheng X, Yang Y,
Fu W, Yi J, Wang J and Du G: The biology, function, and
applications of exosomes in cancer. Acta Pharm Sin B. 11:2783–2797.
2021.
|
|
11
|
Liu Q, Li S, Dupuy A, Mai HL, Sailliet N,
Logé C, Robert JH and Brouard S: Exosomes as new biomarkers and
drug delivery tools for the prevention and treatment of various
diseases: Current perspectives. Int J Mol Sci. 22:77632021.
|
|
12
|
Pitt JM, André F, Amigorena S, Soria JC,
Eggermont A, Kroemer G and Zitvogel L: Dendritic cell-derived
exosomes for cancer therapy. J Clin Invest. 126:1224–1232.
2016.
|
|
13
|
Nikfarjam S, Rezaie J, Kashanchi F and
Jafari R: Dexosomes as a cell-free vaccine for cancer
immunotherapy. J Exp Clin Cancer Res. 39:2582020.
|
|
14
|
Wu R, Gao W, Yao K and Ge J: Roles of
exosomes derived from immune cells in cardiovascular diseases.
Front Immunol. 10:6482019.
|
|
15
|
Elashiry M, Elsayed R and Cutler CW:
Exogenous and endogenous dendritic cell-derived exosomes: Lessons
learned for immunotherapy and disease pathogenesis. Cells.
11:1152021.
|
|
16
|
Viaud S, Terme M, Flament C, Taieb J,
André F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz
T, et al: Dendritic cell-derived exosomes promote natural killer
cell activation and proliferation: A role for NKG2D ligands and
IL-15Ralpha. PLoS One. 4:e49422009.
|
|
17
|
Wang X, He L, Huang X, Zhang S, Cao W, Che
F, Zhu Y and Dai J: Recent progress of exosomes in multiple
myeloma: Pathogenesis, diagnosis, prognosis and therapeutic
strategies. Cancers (Basel). 13:16352021.
|
|
18
|
Vallhov H, Gutzeit C, Hultenby K, Valenta
R, Grönlund H and Scheynius A: Dendritic cell-derived exosomes
carry the major cat allergen Fel d 1 and induce an allergic immune
response. Allergy. 70:1651–1655. 2015.
|
|
19
|
Nazimek K, Bryniarski K and Askenase PW:
Functions of exosomes and microbial extracellular vesicles in
allergy and contact and delayed-type hypersensitivity. Int Arch
Allergy Immunol. 171:1–26. 2016.
|
|
20
|
Collin M and Bigley V: Human dendritic
cell subsets: An update. Immunology. 154:3–20. 2018.
|
|
21
|
Palucka K and Banchereau J: Cancer
immunotherapy via dendritic cells. Nat Rev Cancer. 12:265–277.
2012.
|
|
22
|
Pearce EJ and Everts B: Dendritic cell
metabolism. Nat Rev Immunol. 15:18–29. 2015.
|
|
23
|
Onai N and Manz MG: The STATs on dendritic
cell development. Immunity. 28:490–492. 2008.
|
|
24
|
Macri C, Pang ES, Patton T and O'Keeffe M:
Dendritic cell subsets. Semin Cell Dev Biol. 84:11–21. 2018.
|
|
25
|
Kumar S, Jeong Y, Ashraf MU and Bae YS:
Dendritic cell-mediated Th2 immunity and immune disorders. Int J
Mol Sci. 20:21592019.
|
|
26
|
Austyn JM: Dendritic cells in the immune
system-history, lineages, tissues, tolerance, and immunity.
Microbiol Spectr. 4:2016.
|
|
27
|
Manz MG: Plasmacytoid dendritic cells:
Origin matters. Nat Immunol. 19:652–654. 2018.
|
|
28
|
Upham JW: The role of dendritic cells in
immune regulation and allergic airway inflammation. Respirology.
8:140–148. 2003.
|
|
29
|
Merad M, Sathe P, Helft J, Miller J and
Mortha A: The dendritic cell lineage: Ontogeny and function of
dendritic cells and their subsets in the steady state and the
inflamed setting. Annu Rev Immunol. 31:563–604. 2013.
|
|
30
|
Reizis B: Plasmacytoid dendritic cells:
Development, regulation, and function. Immunity. 50:37–50.
2019.
|
|
31
|
Barrat FJ and Su L: A pathogenic role of
plasmacytoid dendritic cells in autoimmunity and chronic viral
infection. J Exp Med. 216:1974–1985. 2019.
|
|
32
|
Lamiable O, Mayer JU, Munoz-Erazo L and
Ronchese F: Dendritic cells in Th2 immune responses and allergic
sensitization. Immunol Cell Biol. 98:807–818. 2020.
|
|
33
|
Kool M, van Nimwegen M, Willart MAM,
Muskens F, Boon L, Smit JJ, Coyle A, Clausen BE, Hoogsteden HC,
Lambrecht BN and Hammad H: An anti-inflammatory role for
plasmacytoid dendritic cells in allergic airway inflammation. J
Immunol. 183:1074–1082. 2009.
|
|
34
|
Ghislat G and Lawrence T: Autophagy in
dendritic cells. Cell Mol Immunol. 15:944–952. 2018.
|
|
35
|
Sabado RL, Balan S and Bhardwaj N:
Dendritic cell-based immunotherapy. Cell Res. 27:74–95. 2017.
|
|
36
|
Gardner A, de Mingo Pulido Á and Ruffell
B: Dendritic cells and their role in immunotherapy. Front Immunol.
11:9242020.
|
|
37
|
Koltsova EK and Ley K: How dendritic cells
shape atherosclerosis. Trends Immunol. 32:540–547. 2011.
|
|
38
|
Zhu C, Li L, Wang Z, Irfan M and Qu F:
Recent advances of aptasensors for exosomes detection. Biosens
Bioelectron. 160:1122132020.
|
|
39
|
Zhang L and Yu D: Exosomes in cancer
development, metastasis, and immunity. Biochim Biophys Acta Rev
Cancer. 1871:455–468. 2019.
|
|
40
|
Liang Y, Duan L, Lu J and Xia J:
Engineering exosomes for targeted drug delivery. Theranostics.
11:3183–3195. 2021.
|
|
41
|
Han QF, Li WJ, Hu KS, Gao J, Zhai WL, Yang
JH and Zhang SJ: Exosome biogenesis: Machinery, regulation, and
therapeutic implications in cancer. Mol Cancer. 21:2072022.
|
|
42
|
Hessvik NP and Llorente A: Current
knowledge on exosome biogenesis and release. Cell Mol Life Sci.
75:193–208. 2018.
|
|
43
|
Shao H, Im H, Castro CM, Breakefield X,
Weissleder R and Lee H: New technologies for analysis of
extracellular vesicles. Chem Rev. 118:1917–1950. 2018.
|
|
44
|
Zhang Y, Liu Y, Liu H and Tang WH:
Exosomes: Biogenesis, biologic function and clinical potential.
Cell Biosci. 9:192019.
|
|
45
|
He C, Zheng S, Luo Y and Wang B: Exosome
theranostics: Biology and translational medicine. Theranostics.
8:237–255. 2018.
|
|
46
|
Gurunathan S, Kang MH and Kim JH: A
comprehensive review on factors influences biogenesis, functions,
therapeutic and clinical implications of exosomes. Int J
Nanomedicine. 16:1281–1312. 2021.
|
|
47
|
Li W, Li C, Zhou T, Liu X, Liu X, Li X and
Chen D: Role of exosomal proteins in cancer diagnosis. Mol Cancer.
16:1452017.
|
|
48
|
Gurunathan S, Kang MH, Jeyaraj M, Qasim M
and Kim JH: Review of the isolation, characterization, biological
function, and multifarious therapeutic approaches of exosomes.
Cells. 8:3072019.
|
|
49
|
Skotland T, Hessvik NP, Sandvig K and
Llorente A: Exosomal lipid composition and the role of ether lipids
and phosphoinositides in exosome biology. J Lipid Res. 60:9–18.
2019.
|
|
50
|
Skotland T, Sandvig K and Llorente A:
Lipids in exosomes: Current knowledge and the way forward. Prog
Lipid Res. 66:30–41. 2017.
|
|
51
|
Donoso-Quezada J, Ayala-Mar S and
González-Valdez J: The role of lipids in exosome biology and
intercellular communication: Function, analytics and applications.
Traffic. 22:204–220. 2021.
|
|
52
|
Kugeratski FG, Hodge K, Lilla S, McAndrews
KM, Zhou X, Hwang RF, Zanivan S and Kalluri R: Quantitative
proteomics identifies the core proteome of exosomes with syntenin-1
as the highest abundant protein and a putative universal biomarker.
Nat Cell Biol. 23:631–641. 2021.
|
|
53
|
Zhang H, Freitas D, Kim HS, Fabijanic K,
Li Z, Chen H, Mark MT, Molina H, Martin AB, Bojmar L, et al:
Identification of distinct nanoparticles and subsets of
extracellular vesicles by asymmetric flow field-flow fractionation.
Nat Cell Biol. 20:332–343. 2018.
|
|
54
|
Zhu L, Sun HT, Wang S, Huang SL, Zheng Y,
Wang CQ, Hu BY, Qin W, Zou TT, Fu Y, et al: Isolation and
characterization of exosomes for cancer research. J Hematol Oncol.
13:1522020.
|
|
55
|
Gebeyehu A, Kommineni N, Meckes DG Jr and
Sachdeva MS: Role of exosomes for delivery of chemotherapeutic
drugs. Crit Rev Ther Drug Carrier Syst. 38:53–97. 2021.
|
|
56
|
Yu W, Hurley J, Roberts D, Chakrabortty
SK, Enderle D, Noerholm M, Breakefield XO and Skog JK:
Exosome-based liquid biopsies in cancer: Opportunities and
challenges. Ann Oncol. 32:466–477. 2021.
|
|
57
|
Meng W, Hao Y, He C, Li L and Zhu G:
Exosome-orchestrated hypoxic tumor microenvironment. Mol Cancer.
18:572019.
|
|
58
|
Wang Y, Liu J, Ma J, Sun T, Zhou Q, Wang
W, Wang G, Wu P, Wang H, Jiang L, et al: Exosomal circRNAs:
Biogenesis, effect and application in human diseases. Mol Cancer.
18:1162019.
|
|
59
|
Sun Z, Yang S, Zhou Q, Wang G, Song J, Li
Z, Zhang Z, Xu J, Xia K, Chang Y, et al: Emerging role of
exosome-derived long non-coding RNAs in tumor microenvironment. Mol
Cancer. 17:822018.
|
|
60
|
Huang S, Nishiumi S, Asaduzzaman M, Pan Y,
Liu G, Yoshitake K, Maeyama K, Kinoshita S, Nagai K, Watabe S, et
al: Exosome-derived small non-coding RNAs reveal immune response
upon grafting transplantation in Pinctada fucata (Mollusca). Open
Biol. 12:2103172022.
|
|
61
|
Marzec ME, Rząca C, Moskal P and Stępień
E: Study of the influence of hyperglycemia on the abundance of
amino acids, fatty acids, and selected lipids in extracellular
vesicles using TOF-SIMS. Biochem Biophys Res Commun. 622:30–36.
2022.
|
|
62
|
Onozato M, Kobata K, Sakamoto T, Ichiba H
and Fukushima T: LC-MS/MS analysis of Thiol-containing amino acids
in exosomal fraction of serum. J Chromatogr Sci. 58:636–640.
2020.
|
|
63
|
Zhu Q, Huang L, Yang Q, Ao Z, Yang R,
Krzesniak J, Lou D, Hu L, Dai X, Guo F and Liu F: Metabolomic
analysis of exosomal-markers in esophageal squamous cell carcinoma.
Nanoscale. 13:16457–16464. 2021.
|
|
64
|
Zebrowska A, Skowronek A, Wojakowska A,
Widlak P and Pietrowska M: Metabolome of exosomes: Focus on
vesicles released by cancer cells and present in human body fluids.
Int J Mol Sci. 20:34612019.
|
|
65
|
Williams C, Royo F, Aizpurua-Olaizola O,
Pazos R, Boons GJ, Reichardt NC and Falcon-Perez JM: Glycosylation
of extracellular vesicles: Current knowledge, tools and clinical
perspectives. J Extracell Vesicles. 7:14429852018.
|
|
66
|
Gudbergsson JM and Johnsen KB: Exosomes
and autophagy: Rekindling the vesicular waste hypothesis. J Cell
Commun Signal. 13:443–450. 2019.
|
|
67
|
Gonzalez MJ, Kweh MF, Biava PM, Olalde J,
Toro AP, Goldschmidt-Clermont PJ and White IA: Evaluation of
exosome derivatives as bio-informational reprogramming therapy for
cancer. J Transl Med. 19:1032021.
|
|
68
|
Kumar V, Kiran S, Kumar S and Singh UP:
Extracellular vesicles in obesity and its associated inflammation.
Int Rev Immunol. 41:30–44. 2022.
|
|
69
|
Mora EM, Álvarez-Cubela S and Oltra E:
Biobanking of exosomes in the era of precision medicine: Are we
there yet? Int J Mol Sci. 17:132015.
|
|
70
|
Krylova SV and Feng D: The machinery of
exosomes: Biogenesis, release, and uptake. Int J Mol Sci.
24:13372023.
|
|
71
|
Li N, Zhao L, Wei Y, Ea VL, Nian H and Wei
R: Recent advances of exosomes in immune-mediated eye diseases.
Stem Cell Res Ther. 10:2782019.
|
|
72
|
Buzas EI: The roles of extracellular
vesicles in the immune system. Nat Rev Immunol. 23:236–250.
2023.
|
|
73
|
Kim SB: Function and therapeutic
development of exosomes for cancer therapy. Arch Pharm Res.
45:295–308. 2022.
|
|
74
|
Chen J, Li P, Zhang T, Xu Z, Huang X, Wang
R and Du L: Review on strategies and technologies for exosome
isolation and purification. Front Bioeng Biotechnol.
9:8119712021.
|
|
75
|
Lai JJ, Chau ZL, Chen SY, Hill JJ, Korpany
KV, Liang NW, Lin LH, Lin YH, Liu JK, Liu YC, et al: Exosome
processing and characterization approaches for research and
technology development. Adv Sci (Weinh). 9:e21032222022.
|
|
76
|
Chen Y, Zhu Q, Cheng L, Wang Y, Li M, Yang
Q, Hu L, Lou D, Li J, Dong X, et al: Exosome detection via the
ultrafast-isolation system: EXODUS. Nat Methods. 18:212–218.
2021.
|
|
77
|
Zhang X, Xu D, Song Y, He R and Wang T:
Research progress in the application of exosomes in immunotherapy.
Front Immunol. 13:7315162022.
|
|
78
|
Pathan M, Fonseka P, Chitti SV, Kang T,
Sanwlani R, Van Deun J, Hendrix A and Mathivanan S: Vesiclepedia
2019: A compendium of RNA, proteins, lipids and metabolites in
extracellular vesicles. Nucleic Acids Res. 47(D1): D516–D519.
2019.
|
|
79
|
Martínez-Greene JA, Hernández-Ortega K,
Quiroz-Baez R, Resendis-Antonio O, Pichardo-Casas I, Sinclair DA,
Budnik B, Hidalgo-Miranda A, Uribe-Querol E, Ramos-Godínez MDP, et
al: Quantitative proteomic analysis of extracellular vesicle
subgroups isolated by an optimized method combining polymer-based
precipitation and size exclusion chromatography. J Extracell
Vesicles. 10:e120872021.
|
|
80
|
Gandham S, Su X, Wood J, Nocera AL, Alli
SC, Milane L, Zimmerman A, Amiji M and Ivanov AR: Technologies and
standardization in research on extracellular vesicles. Trends
Biotechnol. 38:1066–1098. 2020.
|
|
81
|
Lee K, Shao H, Weissleder R and Lee H:
Acoustic purification of extracellular microvesicles. ACS Nano.
9:2321–2327. 2015.
|
|
82
|
Lin S, Yu Z, Chen D, Wang Z, Miao J, Li Q,
Zhang D, Song J and Cui D: Progress in microfluidics-based exosome
separation and detection technologies for diagnostic applications.
Small. 16:e19039162020.
|
|
83
|
Yao Y, Fu C, Zhou L, Mi QS and Jiang A:
DC-derived exosomes for cancer immunotherapy. Cancers (Basel).
13:36672021.
|
|
84
|
Viaud S, Théry C, Ploix S, Tursz T,
Lapierre V, Lantz O, Zitvogel L and Chaput N: Dendritic
cell-derived exosomes for cancer immunotherapy: What's next? Cancer
Res. 70:1281–1285. 2010.
|
|
85
|
Xia J, Miao Y, Wang X, Huang X and Dai J:
Recent progress of dendritic cell-derived exosomes (Dex) as an
anti-cancer nanovaccine. Biomed Pharmacother. 152:1132502022.
|
|
86
|
Pelissier Vatter FA, Cioffi M, Hanna SJ,
Castarede I, Caielli S, Pascual V, Matei I and Lyden D:
Extracellular vesicle- and particle-mediated communication shapes
innate and adaptive immune responses. J Exp Med.
218:e202025792021.
|
|
87
|
Pitt JM, Charrier M, Viaud S, André F,
Besse B, Chaput N and Zitvogel L: Dendritic cell-derived exosomes
as immunotherapies in the fight against cancer. J Immunol.
193:1006–1011. 2014.
|
|
88
|
Kowal J and Tkach M: Dendritic cell
extracellular vesicles. Int Rev Cell Mol Biol. 349:213–249.
2019.
|
|
89
|
Robbins PD and Morelli AE: Regulation of
immune responses by extracellular vesicles. Nat Rev Immunol.
14:195–208. 2014.
|
|
90
|
Zeng F and Morelli AE: Extracellular
vesicle-mediated MHC cross-dressing in immune homeostasis,
transplantation, infectious diseases, and cancer. Semin
Immunopathol. 40:477–490. 2018.
|
|
91
|
Deb A, Gupta S and Mazumder PB: Exosomes:
A new horizon in modern medicine. Life Sci. 264:1186232021.
|
|
92
|
Wu J, Zhao R, Dai J, Lai G, Khan AU, Yu X,
Wu S, Ouyang J and Sang H: Analysis of differential expression of
long non-coding RNAs in exosomes derived from mature and immature
dendritic cells. Mol Med Rep. 23:1322021.
|
|
93
|
Du Z, Huang Z, Chen X, Jiang G, Peng Y,
Feng W and Huang N: Modified dendritic cell-derived exosomes
activate both NK cells and T cells through the NKG2D/NKG2D-L
pathway to kill CML cells with or without T315I mutation. Exp
Hematol Oncol. 11:362022.
|
|
94
|
Harvey BT, Fu X, Li L, Neupane KR, Anand
N, Kolesar JM and Richards CI: Dendritic cell membrane-derived
nanovesicles for targeted T cell activation. ACS Omega.
7:46222–46233. 2022.
|
|
95
|
Huang F, Jia H, Zou Y, Yao Y and Deng Z:
Exosomes: An important messenger in the asthma inflammatory
microenvironment. J Int Med Res. 48:3000605209032202020.
|
|
96
|
Wiklander OPB, Brennan MÁ, Lötvall J,
Breakefield XO and El Andaloussi S: Advances in therapeutic
applications of extracellular vesicles. Sci Transl Med.
11:eaav85212019.
|
|
97
|
Segura E, Amigorena S and Théry C: Mature
dendritic cells secrete exosomes with strong ability to induce
antigen-specific effector immune responses. Blood Cells Mol Dis.
35:89–93. 2005.
|
|
98
|
Delcayre A, Shu H and Le Pecq JB:
Dendritic cell-derived exosomes in cancer immunotherapy: Exploiting
nature's antigen delivery pathway. Expert Rev Anticancer Ther.
5:537–547. 2005.
|
|
99
|
Rao Q, Ma G, Li M, Wu H, Zhang Y, Zhang C,
Ma Z and Huang L: Targeted delivery of triptolide by dendritic
cell-derived exosomes for colitis and rheumatoid arthritis therapy
in murine models. Br J Pharmacol. 180:330–346. 2023.
|
|
100
|
Zhang Y, Cai Z, Shen Y, Lu Q, Gao W, Zhong
X, Yao K, Yuan J and Liu H: Hydrogel-load exosomes derived from
dendritic cells improve cardiac function via Treg cells and the
polarization of macrophages following myocardial infarction. J
Nanobiotechnology. 19:2712021.
|
|
101
|
Engeroff P and Vogel M: The potential of
exosomes in allergy immunotherapy. Vaccines (Basel).
10:1332022.
|
|
102
|
Sangaphunchai P, Todd I and Fairclough LC:
Extracellular vesicles and asthma: A review of the literature. Clin
Exp Allergy. 50:291–307. 2020.
|
|
103
|
Wang Y, Xiang Y, Xin VW, Wang XW, Peng XC,
Liu XQ, Wang D, Li N, Cheng JT, Lyv YN, et al: Dendritic cell
biology and its role in tumor immunotherapy. J Hematol Oncol.
13:1072020.
|
|
104
|
Metcalfe DD, Pawankar R, Ackerman SJ, Akin
C, Clayton F, Falcone FH, Gleich GJ, Irani AM, Johansson MW, Klion
AD, et al: Biomarkers of the involvement of mast cells, basophils
and eosinophils in asthma and allergic diseases. World Allergy
Organ J. 9:72016.
|
|
105
|
Sastre B, Cañas JA, Rodrigo-Muñoz JM and
Del Pozo V: Novel modulators of asthma and allergy: Exosomes and
MicroRNAs. Front Immunol. 8:8262017.
|
|
106
|
Srinivasan A and Sundar IK: Recent updates
on the role of extracellular vesicles in the pathogenesis of
allergic asthma. Extracell Vesicles Circ Nucl Acids. 2:127–147.
2021.
|
|
107
|
Kraft S, Jouvin MH, Kulkarni N, Kissing S,
Morgan ES, Dvorak AM, Schröder B, Saftig P and Kinet JP: The
tetraspanin CD63 is required for efficient IgE-mediated mast cell
degranulation and anaphylaxis. J Immunol. 191:2871–2878. 2013.
|
|
108
|
Teng ZX, Zhou XC, Xu RT, Zhu FY, Bing X,
Guo N, Shi L, Qi WW, Liu CC and Xia M: Tfh exosomes derived from
allergic rhinitis promote DC maturation through
miR-142-5p/CDK5/STAT3 pathway. J Inflamm Res. 15:3187–3205.
2022.
|
|
109
|
Wahlund CJE, Güclüler G, Hiltbrunner S,
Veerman RE, Näslund TI and Gabrielsson S: Exosomes from
antigen-pulsed dendritic cells induce stronger antigen-specific
immune responses than microvesicles in vivo. Sci Rep.
7:170952017.
|
|
110
|
Mortaz E, Alipoor SD, Varahram M, Jamaati
H, Garssen J, Mumby SE and Adcock IM: exosomes in severe asthma:
Update in their roles and potential in therapy. Biomed Res Int.
2018:28621872018.
|
|
111
|
Liu Y, Sha J, Meng C and Zhu D: The role
of small extracellular vesicles and MicroRNAs in the diagnosis and
treatment of allergic rhinitis and nasal polyps. Mediators Inflamm.
2022:44286172022.
|
|
112
|
Hazrati A, Soudi S, Malekpour K, Mahmoudi
M, Rahimi A, Hashemi SM and Varma RS: Immune cells-derived exosomes
function as a double-edged sword: Role in disease progression and
their therapeutic applications. Biomark Res. 10:302022.
|
|
113
|
Cañas JA, Sastre B, Rodrigo-Muñoz JM and
Del Pozo V: Exosomes: A new approach to asthma pathology. Clin Chim
Acta. 495:139–147. 2019.
|
|
114
|
Hovhannisyan L, Czechowska E and
Gutowska-Owsiak D: The role of non-immune cell-derived
extracellular vesicles in allergy. Front Immunol.
12:7023812021.
|
|
115
|
Hough KP, Wilson LS, Trevor JL,
Strenkowski JG, Maina N, Kim YI, Spell ML, Wang Y, Chanda D, Dager
JR, et al: Unique lipid signatures of extracellular vesicles from
the airways of asthmatics. Sci Rep. 8:103402018.
|
|
116
|
Kim SH, Bianco NR, Shufesky WJ, Morelli AE
and Robbins PD: Effective treatment of inflammatory disease models
with exosomes derived from dendritic cells genetically modified to
express IL-4. J Immunol. 179:2242–2249. 2007.
|
|
117
|
Yin W, Ouyang S, Li Y, Xiao B and Yang H:
Immature dendritic cell-derived exosomes: A promise subcellular
vaccine for autoimmunity. Inflammation. 36:232–240. 2013.
|
|
118
|
Lin J, Huang N, Li M, Zheng M, Wang Z,
Zhang X, Gao H, Lao Y, Zhang J and Ding B: Dendritic cell-derived
exosomes driven drug co-delivery biomimetic nanosystem for
effective combination of malignant melanoma immunotherapy and gene
therapy. Drug Des Devel Ther. 17:2087–2106. 2023.
|
|
119
|
Huda MN, Nafiujjaman M, Deaguero IG,
Okonkwo J, Hill ML, Kim T and Nurunnabi M: Potential use of
exosomes as diagnostic biomarkers and in targeted drug delivery:
Progress in clinical and preclinical applications. ACS Biomater Sci
Eng. 7:2106–2149. 2021.
|
|
120
|
Esser J, Gehrmann U, D'Alexandri FL,
Hidalgo-Estévez AM, Wheelock CE, Scheynius A, Gabrielsson S and
Rådmark O: Exosomes from human macrophages and dendritic cells
contain enzymes for leukotriene biosynthesis and promote
granulocyte migration. J Allergy Clin Immunol. 126:1032–1040.
1040.e1–e4. 2010.
|
|
121
|
Choi HW, Suwanpradid J, Kim IH, Staats HF,
Haniffa M, MacLeod AS and Abraham SN: Perivascular dendritic cells
elicit anaphylaxis by relaying allergens to mast cells via
microvesicles. Science. 362:eaao06662018.
|
|
122
|
Li Q, Wang H, Peng H, Huyan T and Cacalano
NA: Exosomes: Versatile nano mediators of immune regulation.
Cancers (Basel). 11:15572019.
|
|
123
|
Huang L, Zhang X, Wang M, Chen Z, Yan Y,
Gu W, Tan J, Jiang W and Ji W: Exosomes from thymic stromal
lymphopoietin-activated dendritic cells promote Th2 differentiation
through the OX40 ligand. Pathobiology. 86:111–117. 2019.
|
|
124
|
Zhu H, Wang K, Wang Z, Wang D, Yin X, Liu
Y, Yu F and Zhao W: An efficient and safe MUC1-dendritic
cell-derived exosome conjugate vaccine elicits potent cellular and
humoral immunity and tumor inhibition in vivo. Acta Biomater.
138:491–504. 2022.
|
|
125
|
Johnsen KB, Gudbergsson JM, Skov MN,
Pilgaard L, Moos T and Duroux M: A comprehensive overview of
exosomes as drug delivery vehicles-endogenous nanocarriers for
targeted cancer therapy. Biochim Biophys Acta. 1846:75–87.
2014.
|
|
126
|
Bianco NR, Kim SH, Morelli AE and Robbins
PD: Modulation of the immune response using dendritic cell-derived
exosomes. Methods Mol Biol. 380:443–455. 2007.
|
|
127
|
Schülke S: Induction of interleukin-10
producing dendritic cells as a tool to suppress allergen-specific T
helper 2 responses. Front Immunol. 9:4552018.
|
|
128
|
Bianco NR, Kim SH, Ruffner MA and Robbins
PD: Therapeutic effect of exosomes from indoleamine
2,3-dioxygenase-positive dendritic cells in collagen-induced
arthritis and delayed-type hypersensitivity disease models.
Arthritis Rheum. 60:380–389. 2009.
|
|
129
|
Jia Z, Liu J, Li B, Yi L, Wu Y, Xing J,
Wang L, Wang J and Guo L: Exosomes with FOXP3 from gene-modified
dendritic cells ameliorate the development of EAE by regulating the
balance of Th/Treg. Int J Med Sci. 19:1265–1274. 2022.
|
|
130
|
Yu D, Liu JQ, Mo LH, Luo XQ, Liu ZQ, Wu
GH, Yang LT, Liu DB, Wang S, Liu ZG and Yang PC: Specific
antigen-guiding exosomes inhibit food allergies by inducing
regulatory T cells. Immunol Cell Biol. 98:639–649. 2020.
|
|
131
|
Kim SH, Bianco N, Menon R, Lechman ER,
Shufesky WJ, Morelli AE and Robbins PD: Exosomes derived from
genetically modified DC expressing FasL are anti-inflammatory and
immunosuppressive. Mol Ther. 13:289–300. 2006.
|
|
132
|
Näslund TI, Gehrmann U, Qazi KR, Karlsson
MC and Gabrielsson S: Dendritic cell-derived exosomes need to
activate both T and B cells to induce antitumor immunity. J
Immunol. 190:2712–2719. 2013.
|
|
133
|
Iberg CA and Hawiger D: Natural and
induced tolerogenic dendritic cells. J Immunol. 204:733–744.
2020.
|
